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1. Introduction 
Coronary artery disease is a major health problem and a major cause of death in most 
industrialized and developing countries. On the other hand, recent basic and clinical studies 
have illustrated that oxidative stress plays an important role in the progression of coronary 
atherosclerosis (Kunsch C & Medford RM., 1999; Azumi H et al., 2002). Oxidative stress 
leads to oxidation of products in vivo and numerous oxidation products have been 
investigated and their significance examined in atherosclerotic disease (Steinberg D et al., 
1997; Ehara S et al., 2001). 7-Ketocholesterol is known to be a major component of the 
cholesterol oxidation product, oxysterols, and is found in high concentrations in 
atherosclerotic plaques which contribute to the development of atherosclerosis (Brown AJ & 
Jessup W., 1998; Smith LL et al., 1996). Thus, 7-ketocholesterol is considered to be an 
important target factor in the prevention of coronary events and reflects the pathogenesis of 
coronary artery disease, and therefore has clinical applications. However, the clinical 
significance of blood 7-ketocholesterol concentrations (7KCHO) are not fully understood, 
because it is difficult to analyze these concentrations accurately. In the present study, we 
established a measuring system for serum 7-ketocholesterol concentrations (s-7KCHO) 
using gas chromatography mass spectrometry technique and attempted to clarify the 
clinical significance of s-7KCHO in the progression of coronary atherosclerosis using 
coronary angiography and intra-vascular ultrasound (IVUS).  
2. Measurement of s-7KCHO 
7KCHO was purchased from Sigma Chemicals Co. (St. Louis, MO, USA). 
24,25,25,25,26,26,26,-d7-7-Ketocholesterol (d7-7KCHO) was prepared by Isotec (Miamisburg, 
OH, USA), and used as an internal standard. Dried pyridine was purchased from Merck 
(Darmstadt, Germany). Serum blood samples were stored immediately at −80°C , and were 
used as samples for the s-7KCHO assay within 1 week. A 500 μl aliquot of serum was mixed 
with 50 μl internal standard stock solution (10 μg/ml of d7-7KCHO dissolved in 1 ml 
toluene/ethyl acetate = 1:1, v/v), and 3 ml of diethyl ether/hexane (2:3, v/v) containing 
0.01% BHT. The mixture was flushed with nitrogen gas and mixed in a rotary shaker for 
30 min at room temperature. After centrifugation at 2000 × g for 15 min, the organic phase 
was collected and dried under nitrogen gas. The residue was dissolved in 1 ml of 
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toluene/ethyl acetate (1:1, v/v), and applied to 3 ml “Diol” extraction columns (Bakerbond 
Spe, J.T. Baker Inc., Phillipsburg, NJ) that had been conditioned with the same solvent. After 
collection of the first eluted fraction under mild vacuum, the columns were eluted with 
another 2 ml of the same solvent. Three ml the of eluent was dried under nitrogen gas, and 
the residues were dissolved in 2 ml of diethyl ether, following which 500 μl of 20% 
potassium hydroxide dissolved in methanol was added. After mixing in a rotary shaker for 
3 h, the mixture was neutralized by 20% acetic acid. To separate the organic phase from the 
aqueous phase, 1 ml of water was added and centrifuged. The organic phase was s 
eparated, added again to 1 ml of water, and centrifuged. The pooled organic fractions  
were dried under nitrogen gas. Dried samples were derivatized with 200 μl of  
o-methylhydroxylamine/hydrochloride dissolved in dried pyridine at 70°C for 2 h, and 100 
μl of N,O-bis(trimethyl-silyl)trifluoroacetamide (BSTFA) at 70°C for 2 h. Then 1 μl aliquots 
were injected into a Varian GC/MS system consisting of a gas chromatography (CP-3800), 
an ion trap mass spectrometry (Saturn-2000), and an auto-sampler (CP-8400). The whole 
instrument set was controlled by a computer. The column used was a commercial product 
“WCOT Fused Silica (30 m × 0.25 mm i.d.) Coating CP-SIL 8 CB Low Bleed/MS” (Varian 
Inc., Palo Alto, CA, USA). Helium was used as carrier gas at a flow rate of 0.8 ml/min. The 
injection temperature was set at 270 °C (split ratio 1:4) and the initial column temperature at 
60 °C. The analysis was run by holding the initial temperature for 1 min, and then increasing 
it at a rate of 20°C/min up to 280°C and 10°C/min up to 300°C. Thereafter the temperature 
was held at 300 °C for 10 min and was then increased again at a rate of 15 °C/min until 
330 °C. The total running time was 31 min. The transfer line was maintained at 250 °C and 
the ion source at 220 °C. The electron ionization was performed by 70 eV ionized energy. 
The number of monitoring ions used was 471 for 7KCHO and 478 for internal standard (d7-
7KCHO). In this assay system, recovery test was 95%, intra-assay coefficients of variation 
were <5%, and the detection limit of the assay was 6.2ng/ml.  
3. Angiographic study 
3.1 Study population 
One hundred and thirty-nine subjects with coronary artery disease (CAD; subjects with 
stable angina pectoris or acute myocardial infarction) and 43 subjects with normal coronary 
arteries were enrolled. We examined relation of s-7-KCHO and findings of coronary 
angiography or coronary risk factors. 
3.2 Methods of coronary angiography  
Coronary angiography was performed by transfemoral or transbrachial approaches using a 
standard technique. Two experienced angiographers who were single blinded to the study 
reviewed all coronary angiograms. The severity of coronary stenosis was assessed with a 
worst-view projection. The percentage of luminal narrowing was recorded according to the 
American Heart Associations reporting system. Significant stenotic lesion was defined as 
≥75% diameter stenosis, and the extent of coronary atherosclerosis was classified by the 
number of vessels with significant stenotic lesions. Lesions in the left main trunk were not 
observed in the present study. Of the study population, 68 subjects suffered from acute 
myocardial infarction (AMI). All AMI subjects had confirmed culprit lesion, which was a 
total or subtotal occlusion by coronary angiography. Diagnosis of AMI was based on: (1) a 
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clinical history of central chest pressure pain, or tightness for 30 min or more, (2) ST-
segment elevation greater than 0.1 mV in at least one standard or precordial lead, and (3) a 
rise in the serum creatine kinase concentration to more than twice the normal laboratory 
value. All subjects with normal coronary artery (NCA) were performed coronary 
angiography for evaluation of chest pain and/or abnormality of electrocardiograph and 
NCA was defined as the absence of significant stenosis and spastic reaction which was 
provoked by intracoronary administration of acetylcholine. 
3.3 Results 
Patient characteristics are shown in Table 1. Age, proportion of male subjects, diabetes 
mellitus and smoking were significantly higher in subjects with CAD than in those with 
NCA. Considering the serum lipid concentrations, there were significantly higher TC, LDL-
C and triglyceride concentrations in subjects with NCA than in those with CAD; however, 
the serum lipid data were similar in subjects without antihyperlipidemic treatment (data not 
shown). HDL-C concentrations were significantly lower in subjects with CAD than in those 
with NCA. hs-CRP concentrations were significantly higher in subjects with CAD than in 
those with NCA.  
 
Data are expressed mean ± SD( ): % 
*p<0.05 vs NCA, **p<0.01 vs NCA 
NCA: Normal coronary artery 
CAD: Coronary artery disease 
BMI: body mass index 
LDL: low-density lipoprotein 
HDL: high-density lipoprotein 
Table 1. Baseline clinical characteristics 
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Data are expressed mean ± SD *p<0.01 vs NCA 
Fig. 1. Comparisons of 7-ketocholesterol concentrations between subjects with normal 
coronary artery and coronary artery disease  
 
Data are expressed mean ± SD  
*p<0.05 vs 1VD 
1VD (n=85): 1-vessel disease 
2VD (n=36): 2-vessel disease 
3VD (n=18): 3-vessel disease 
Fig. 2. Relation of 7-ketocholesterol concentrations and number of affected vessels. 
Comparisons of s-7KCHO between NCA and CAD subjects are shown in Fig. 1. s-7KCHO 
were significantly higher in subjects with CAD than in those with NCA (p < 0.01) (NCA: 
19.0 ± 11.3 ng/ml, CAD: 32.4 ± 23.1 ng/ml). We also examined s-7KCHO in subjects without 
taking statins. s-7KCHO were significantly higher in subjects with CAD than in those with 
NCA (p < 0.01) (NCA: 17.7 ± 9.6 ng/ml, CAD: 35.4 ± 25.4 ng/ml). The relationship between 
s-7KCHO and the number of affected vessels is shown in Fig. 2. s-7KCHO were significantly 
higher in subjects with 2 or 3 vessel disease than those with single vessel disease (p < 0.05, p 
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< 0.05, respectively) (1-vessel disease: 28.0 ± 21.1 ng/ml, 2-vessel disease: 39.0 ± 25.6 ng/ml, 
3-vessel disease: 41.3 ± 23.2 ng/ml). Comparisons of s-7KCHO between subjects with stable 
angina pectoris and those with AMI are shown in Fig. 3. s-7KCHO were significantly higher 
in subjects with AMI than in those with stable angina pectoris even though the number of 
affected vessels were similar in the two groups (p < 0.01) (Stable angina pectoris: 26.1 ± 15.2 
ng/ml, AMI: 39.1 ± 27.7 ng/ml). 
 
Data are expressed mean ± SD  
*p<0.01 vs stable AP  
Stable AP (n=69): stable angina pectoris 
AMI (n=68): acute myocardial infarction 
Fig. 3. Comparisons of 7-ketocholesterol concentrations between subjects with stable angina 
pectoris and acute myocardial infarction. 
 
Table 2. Correlation between 7-keto cholesterol concentration and serum parameters. 
Correlation between serum parameters and s-7KCHO in CAD subjects were shown in Table 2. 
There were no significant correlations between TC or LDL cholesterol concentrations and s-
7KCHO. Conversely, s-7KCHO had significant correlations with HDL-cholesterol and hs-CRP 
concentrations. Other coronary risk factors such as age, sex, hypertension, diabetes mellitus, 
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obesity, smoking, and family history of CAD were not related to s-7KCHO (data not shown). 
We also examined relationship between statin use and s-7KCHO. Subjects with statin use 
showed higher s-7KCHO than those without statin use, although the difference was not 
significant (p=0.09) (without statin use: 28.9 ± 19.9 ng/ml, statin use: 35.4 ± 25.7 ng/ml). 
Multivariate analysis revealed that s-7KCHO were selected as an independent variable for 
CAD (p < 0.01, Table 3). In CAD subjects, the presence of acute myocardial infarction, 
number of affected vessels, and high sensitive C-reactive protein concentrations strongly 
correlated with s-7KCHO (p < 0.01, < 0.05, < 0.05, respectively, Table 4).  
 
OR: odds ratio, CI: confidence interval, (n=182) 
Table 3. Results of multivariate logistic regression analysis for coronary artery disease. 
 
R2=0.27, F value=3.8, p<0.0001, (n=139) 
Table 4. Results of multiple regression analysis for 7-ketocholesterol concentrations in 
subjects with coronary artery disease. 
Our angiographic study indicated that high s-7KCHO were closely associated with acute 
myocardial infarction. On the other hand, recent clinical studies using IVUS have clarified 
that coronary artery plaque already exists in subjects with normal coronary artery, which is 
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diagnosed by coronary angiography. Furthermore, it has been reported that almost 70% of 
culprit lesion on acute myocardial infarction, now called acute coronary syndrome, which is 
highly correlated with mortality, occurs in less than 50% of angiographic stenosis (Falk E et 
al., 1995). Therefore, it is difficult to predict the occurrence of acute coronary syndrome and 
it is important that we consider the presence of coronary atherosclerosis; especially presence 
of vulnerable plaque, before angiographic stenosis. IVUS studies have clarified the future of 
plaque on acute coronary syndrome; plaque volume is large and shows abnormal plaque 
quality (Yamagishi M et al., 2000; Namiki N et al., 1999; Kotani J et al., 2003) such as 
eccentricity, lipid pool and mild calcified lesions. Therefore, next, we examined relation of s-
7KCHO and coronary plaque in angiographic normal stage using IVUS.  
4. IVUS study 
4.1 Study population 
66 subjects with normal coronary artery diagnosed by coronary angiography were enrolled. 
Proxymal range of left anterior descending coronary artery was observed by intravascular 
ultrasound using auto-pullback methods and examined relation of s-7KCHO and coronary 
plaque. 
4.2 Methods of IVUS study 
Coronary angiography was performed the transfemoral approach using a standard 
technique. Two experienced angiographers reviewed all coronary angiograms and 
confirmed that there were no stenotic lesion, and consequently performed IVUS study. To 
avoid spasm, 1 to 2 mg of nitroglycerin was administrated before insertion of the 0.014-
inch coronary guidewire and IVUS catheter through a coronary guiding catheter. After 
the IVUS catheter was inserted more than 20 mm beyond proximal of left descending 
coronary artery (LAD), a motorized auto pullback was performed at 1 mm/second 
velocity and the percent plaque volume was calculated for 20 mm length of LAD proximal 
side as plaque quantity. We also evaluated plaque quality, such as eccentricity, 
calcification and lipid pool into plaque. Eccentricity was identified when the minimum 
dimension of plaque thickness/dimension of the other side plaque thickness at max 
plaque area was less than 0.5. Calcification was defined when a high echo area with back 
reflection was detected and lipid pool was defined as when echo lucent zone was detected 
during the observation period. 
4.3 Results 
There were significantly positive correlation between s-7-KCHO and %Plaque volume 
(r=0.37, p<0.001, Fig. 4.); furthermore, multiple regression analysis showed that high s-7-
KCHO were selected as independent variables for %Plaque volume (p<0.05). On the other 
hand, subjects with high s-7-KCHO (≧20ng/ml, n=33) were detected high incidence of 
abnormal plaque quality such as eccentric plaque (76%), mild calcified lesion (64%) and 
lipid pool (30%) (Table 5). Fig. 5. shows the relationship of high s-7-KCHO and degree of 
calcification. Subjects with high s-7-KCHO had mild degree and plural number of 
calcification into plaque. 
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Fig. 4. Correlation between 7-keto cholesterol concentration and %Plaque volume. 
 
 
Table 5. 7-ketocholesterol concentrations and abnormality of plaque quality. 
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Fig. 5. Feature of calcification in subjects with high 7-ketocholesterol concentrations. 
5. Discussion 
In angiographic study, s-7KCHO were significantly higher in subjects with CAD than in 
those with NCA; furthermore, multiple regression analysis revealed that s-7KCHO were 
selected as independent variable for the presence of CAD as a subordinate factor. The 
presence of AMI, number of affected vessels, and hs-CRP concentrations strongly correlated 
with s-7KCHO in CAD subjects. Furthermore, IVUS study indicated that s-7KCHO reflected 
vulnerable coronary plaque which is not detectable by coronary angiography. 
7KCHO is excessive in advanced atherosclerotic plaques (Brown AJ & Jessup W., 1998), and 
contributes to the development of atherosclerosis (Smith LL et al., 1996). Furthermore, 
7KCHO causes apoptosis (Miyashita Y et al., 1997) and inhibits migration of smooth muscle 
cells (Oyama T et a.l, 2001). These findings suggest that accumulation of 7KCHO in 
atherosclerotic lesions may decrease the amount of cells and render atherosclerotic plaques 
unstable. Thus, 7KCHO is important not only in the progression of coronary atherosclerosis 
but is also the cause of plaque rupture which is a major factor of AMI. In the present study, 
s-7KCHO reflected the severity of coronary atherosclerosis, estimated by coronary 
angiography; furthermore, s-7KCHO strongly correlated with presence of AMI and 
vulnerable coronary plaque. Therefore, s-7KCHO may reflect 7KCHO in the coronary artery 
plaque and is expected to be a predictor of AMI occurrence which is strongly associated 
with mortality.  
Hypercholesterolemia is established as one of the most important coronary risk factors; 
however, the average serum TC or LDL-C concentration in subjects with CAD often appears 
to be within the normal range. The present study also indicated that serum TC or LDL-C 
concentrations were not higher in CAD subjects than in NCA subjects. Furthermore, there is 
no relationship between serum TC or LDL-C concentrations and s-7KCHO. Another study 
also indicated that blood 7KCHO had no relationship with blood cholesterol concentrations 
in CAD subjects (Tomasik A et al., 2000). Therefore, these results suggest that s-7KCHO is a 
different marker from blood cholesterol concentrations even though 7KCHO were oxidation 
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products of cholesterol. This allows us to predict coronary events which are not detectable 
by serum TC or LDL-C concentrations if we can measure s-7KCHO in the clinic. In a basic 
study, degenerative LDL such as small sized LDL or glycated LDL was shown to be easily 
oxidized (de Graaf J et al., 1991; Lyons TJ., 1992), consequently, promoting atherosclerotic 
lesion. Some clinical studies emphasized an increase in degenerative LDL in CAD (Austin 
MA & Krauss RM., 1984; Krauss RM., 1994). 7KCHO may relate to oxidation products of 
degenerative LDL, however, the relationship is not fully understood. Therefore, further 
studies are required to investigate the significance of s-7KCHO from the perspective of 
precise lipid profiles. 
Among the serum lipid concentrations, only HDL-C had significant relationship with  
s-7KCHO. A number of studies reported that low HDL-C concentrations were inversely 
related to the risk of cardiovascular disease (Castelli WP et al., 1986; Rhoads GG et al., 1976) 
and the present study may indicate that HDL retards the progression of coronary 
atherosclerosis by decreasing 7KCHO in the coronary vessel wall or blood flow. The 
relationship between HDL-C concentrations and s-7KCHO in coronary atherosclerosis is not 
fully understood. Recently, however, Terasaka reported that HDL exerted a protective effect 
against apoptosis induced by 7KCHO using ATP-binding cassette transporter ABCG1+/+ 
mice (Terasaka N et al., 2007). The ATP-binding cassette transporter ABCG1 was recently 
shown to promote efflux of cholesterol from macrophage to HDL and reverse the 
relationship between HDL-C concentrations and s-7KCHO. This may be partly explained by 
the role of ATP-binding cassette transporter ABCG1.  
In the present study, there was a significant correlation between s-7KCHO and hs-CRP 
concentrations in CAD subjects. Furthermore, these two factors had a significant 
association with each other after adjustment of related factors. Thus, this result suggests 
that s-7KCHO are closely associated with inflammation in coronary atherosclerosis. 
Recent clinical investigations showed that inflammation plays an important role in the 
progression of atherosclerosis (Ross R., 1999; Libby P et al., 2002) and epidemiological 
studies clarified the link between high levels of CRP concentration and cardiovascular 
events (Ridker PM et al., 2002; Matsumoto K et al., 2003). Paul et al. showed that CRP is 
present in the human arterial intima of the atherosclerotic lesion by histological 
examination (Paul A et al., 2004); furthermore, Kobayashi et al. reported that, by using a 
sample of directional coronary atherectomy, expression of CRP was colocalized with 
p22phox and CRP directly induced p22phox expression generating reactive oxygen 
species in cultured smooth muscle cells (Kobayashi S et al., 2003). Therefore, CRP may 
promote the production of 7-KCHO in coronary artery plaques; consequently, increasing 
s-7KCHO. However, some reports indicate that oxysterol influences proinflammatory 
properties (Wang N et al., 1996; Liu Y et al., 1997). Joffre et al. reported that 7KCHO 
enhanced interleukin-8 gene expression using porcine retinal pigment epithelial cells 
(Joffre C et al., 2007). Interleukin-8 is a proinflammatory and chemotactic cytokine which 
might play a crucial role in the recruitment of monocytes and T lymphocytes into the 
arterial subendothelial space, consequently, promoting atherosclerotic lesion (Terkeltaub 
R et al., 1998). Furthermore, interleukin-8 could have a potential atherogenic role by 
inhibiting the local tissue inhibitor of metalloproteinase-1 expression, thereby leading to 
an imbalance between matrix metalloproteinases and metalloproteinase-1 at focal sites  
of atherosclerotic plaque, and to local extracellular degradation, causing the rupture  
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of atheromatous plaques (Moreau M et al., 1999). Thus, 7KCHO and inflammation in 
coronary atherosclerosis are closely associated with each other and may promote 
vulnerable plaque formation. 
In IVUS study, calcification was frequently detected in subjects with high s-7KCHO 
compared with low s-7KCHO.  
Calcification into plaque is vulnerable and has been controversial. However, some clinical 
studies have shown that coronary calcification, which is detected by computed tomography 
is a powerful predictor for cardiac events (Kondos GT et al., 2003; Greenland P et al., 2004). 
Raggi et al (Raggi P et al., 2003) reported that coronary calcification identified by electron-
beam computed tomography was highly prevalent in patients with acute myocardial 
infarction; thus, coronary calcification might be indicated in the presence of vulnerable 
plaque. Furthermore, a recent IVUS study (Ehara S et al., 2004) reported that culprit lesion 
on acute coronary syndrome had significantly high incidence of mild calcification than those 
with stable angina pectoris. Therefore, our results can be interpreted as follows: from the 
viewpoint of calcification, subjects with high s-7KCHO already have vulnerable plaque in 
early stage coronary atherosclerosis. 
6. Conclusion 
Our data which is accurately measured s-7KCHO indicate that high s-7KCHO are closely 
associated with not only progression of coronary atherosclerosis but also formation of 
vulnerable plaque. To achieve the clinical usefulness, simple and reliable methods to 
measure blood 7KCHO concentrations are needed and examination of many clinical studies 
investigating the significance of s-7KCHO in diagnosis and treatment are required. 
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